The purpose of this study was to compare the inci-dence and severity of rejection episodes in a group of dence and severity of rejection episodes in a group of children receiving living related orthotopic liver transchildren receiving living related orthotopic liver transplants (LRLT) versus patient
The natural history of untreated focal allograft rejection in liver transplant recipients
โ Scribed by McVicar, John P. ;Kowdley, Kris V. ;Bacchi, Carlos E. ;Barr, Darlene ;Marsh, Christopher L. ;Perkins, James D. ;Carithers, Robert L.
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1996
- Tongue
- English
- Weight
- 613 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1074-3022
No coin nor oath required. For personal study only.
โฆ Synopsis
Focal rejection involves less than 20% of portal tracts in liver allograft biopsy results. The clinical significance of "focal" rejection on protocol liver biopsy results is unknown. The purpose of this study was to prospectively determine the incidence of clinically significant rejection in patients with focal rejection after orthotopic liver transplantation. Biopsy specimens from 165 consecutive transplantations in 149 patients were analyzed. After protocol biopsy specimens were obtained, patients with focal or mild rejection were observed. Fifty of 583 (8.6%) protocol biopsy results cute allograft rejection after orthotopic liver A transplant (OLT) is common, occurring in 50% to 80% of recipient^.'.^ Acute rejection is usually responsive to increased immunosuppression but may occasionally be refractory to treatment and lead to graft loss. Increased immunosuppression for acute rejection may lead to an increased incidence of infectious complication^.^ Determining the optimal level of immunosuppression necessary to prevent rejection is difficult. One suggested strategy is biopsy-guided immunosuppression,*-' in which biopsy specimens are obtained on a scheduled, protocol basis, and rejection episodes are treated according to histology. Proponents of this strategy point out that changes in liver function tests after OLT are not specific enough to diagnose rejection. In addition, rejection is diagnosed earlier when protocol biopsies are performed, allowing earlier diagnosis and treatment of acute rejection after OLT.
The histological criteria for allograft rejection have
๐ SIMILAR VOLUMES
Although rare in the pediatric population, the natural history of hepatitis C virus (HCV) recurrence in pediatric patients undergoing orthotopic liver transplantation (OLT) for end-stage liver disease secondary to HCV has not been well described. We performed an analysis of all 67 pediatric patients
Interferon alfa-2b (IFN-alpha) therapy has been shown to be effective in the treatment of viral hepatitis B (HBV) or viral hepatitis C (HCV) in patients who did not undergo transplantation. However, in allograft recipients, treatment with IFN-alpha often leads to allograft rejection. The aim of the
Central perivenulitis (CP) in the allograft liver can be associated with portal-based acute cellular rejection and autoimmune hepatitis or can occur in isolation (isolated CP). Although several studies have demonstrated the significance of CP, the prevalence and natural history of untreated isolated
Mycophenolate mofetil (MMF) has been used to rescue liver allografts with steroid-resistant rejection (SRR). However, the long-term outcome of these patients is not known. This study evaluates the long-term outcome of MMF rescue therapy for SRR in pediatric liver allograft recipients. Twenty-six chi